In vitro and in vivo CT imaging using bismuth sulfide modified with a highly biocompatible Pluronic F127

Nanotechnology

Volumn 25, Issue 29, 2014, Pages

  Chen, Jun ^a   Yang, Xiao Quan ^a   Meng, Yuan Zheng ^a   Huang, Huan Huan ^a   Qin, Meng Yao ^a   Yan, Dong Mei ^a   Zhao, Yuan Di ^a   Ma, Zhi Ya ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

biocompatibility; bismuth sulfide; CT contrast agent; nanoparticle; Pluronic F127

Indexed keywords

AMINO ACIDS; ATOMIC EMISSION SPECTROSCOPY; BIOCOMPATIBILITY; BISMUTH; BLOOD; CELLS; NANOPARTICLES; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL ANALYSIS; BISMUTH SULFIDE; CIRCULATION HALF-LIFES; CONTRAST AGENT; CONTRAST ENHANCEMENT; PLURONIC F-127;

PROBES;

BIOMATERIAL; BISMUTH; BISMUTH SULFIDE; CONTRAST MEDIUM; NANOPARTICLE; POLOXAMER; SULFIDE;

ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; DRUG EFFECTS; MOUSE; PROCEDURES; SYNTHESIS;

ANIMALS; BIOCOMPATIBLE MATERIALS; BISMUTH; CELL SURVIVAL; CONTRAST MEDIA; MICE; MICE, INBRED BALB C; NANOPARTICLES; POLOXAMER; SULFIDES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84904016252     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/25/29/295103     Document Type: Article

References (44)

1. Willi A K 2006 X-ray computed tomography Phys. Med. Biol. 51 R29
2. Badea C T, Drangova M, Holdsworth D W and Johnson G A 2008 In vivo small-animal imaging using micro-CT and digital subtraction angiography Phys. Med. Biol. 53 R319
3. Schambach S J, Bag S, Schilling L, Groden C and Brockmann M A 2010 Application of micro-CT in small animal imaging Methods 50 2
4. Mesanovic N, Huseinagic H and Mujagic S 2013 3D tracheobronchial airway three segmentation from thorax CT images Biomed. Eng. Appl. Basis Commun. 25 1350015
5. Sun J G, Adie S G, Chaney E J and Boppart S A 2013 Segmentation and correlation of optical coherence tomography and x-ray images for breast cancer diagnostics J. Innov. Opt. Health Sci. 6 1350015
6. Hill D L G, Batchelor P G, Holden M and Hawkes D J 2001 Medical image registration Phys. Med. Biol. 46 R1
7. Smith-Bindman R, Lipson J, Marcus R, Kim K P, Mahesh M, Gould R, Berrington A G and Miglioretti D L 2009 Radiation dose associated with common computed tomography examinations and the associated life time attributable risk of cancer Arch. Intern. Med. 169 2078
8. Rode U and Müller R 1998 Transformation of the ionic x-ray contrast agent diatrizoate and related triiodinated benzoates by trametes versicolor Appl. Environ. Microbiol. 64 3114
9. El-Gendy N, Aillon K L and Berkland C 2010 Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent Int. J. Pharm. 391 305
10. Gaspari F, Perico N, Ruggenenti P, Mosconi L, Amuchastegui C S, Guerini E, Daina E and Remuzzi G 1995 Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate J. Am. Soc. Nephrol. 6 257
11. Chou L Y T, Ming K and Chan W C W 2011 Strategies for the intracellular delivery of nanoparticles Chem. Soc. Rev. 40 233
12. Popovic Z et al 2010 Nanoparticle size series for in vivo fluorescence imaging Angew. Chem. Int. Ed. 49 8649
13. Szebeni J 2005 Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity Toxicology 216 106
14. Kim D, Park S, Lee J H, Jeong Y Y and Jon S 2007 Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo x-ray computed tomography imaging J. Am. Chem. Soc. 129 7661
15. Rabin O, Perez J M, Grimm J, Wojtkiewicz G and Weissleder R 2006 An x-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles Nat. Mater. 5 118
16. Oh M H, Lee N, Kim H, Park S P, Piao Y, Lee J, Jun S W, Moon W K, Choi S H and Hyeon T 2011 Large-scale synthesis of bioinert tantalum oxide nanoparticles for x-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping J. Am. Chem. Soc. 133 5508
17. Liu Y L, Ai K L, Liu J H, Yuan Q H, He Y Y and Lu L H 2012 Hybrid BaYbF5 nanoparticles: novel binary contrast agent for high-resolution in vivo x-ray computed tomography angiography Adv. Healthcare. Mater. 1 461
18. Fang Y, Peng C, Guo R, Zheng L, Qin J, Zhou B, Shen M, Lu X, Zhang G and Shi X 2013 Dendrimer-stabilized bismuth sulfide nanoparticles: synthesis, characterization, and potential computed tomography imaging applications Analyst 138 3172
19. Pan D, Williams T, Senpan A, Allen J. S, Scott M J, Gaffney P J, Wickline S A and Lanza G M 2009 Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticles J. Am. Chem. Soc. 131 15522
20. Pan D et al 2010 Computed tomography in color: molecular imaging of ruptured atherosclerotic plaque with fibrin-specific spectral CT nanobeacons Angew. Chem. Int. Ed. 49 9635
21. Joseph M K, Rebecca E J, Priya P K, Anthony M R V, Ramana K, Nathan C G, Erkki R, Dwayne S and Michael J S 2011 X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles Angew. Chem. Int. Ed. 50 12308
22. Hossain M, Luo Y, Sun Z, Wang C, Zhang M, Fu H, Qiao Y and Su M 2012 X-ray enabled detection and eradication of circulating tumor cells with nanoparticles Biosens. Bioelectron. 38 348
23. Ai K, Liu Y, Liu J, Yuan Q, He Y and Lu L 2011 Large-scale synthesis of Bi2S3 nanodots as a contrast agent for in vivo x-ray computed tomographyimaging Adv. Mater. 23 4886
24. Didisheim P, Pavlovsky M and Kobayashi I 1972 Factors affecting hemostatic plug formation in an extracorporeal model Ann. Ny. Acad. Sci. 201 307
25. Jain T K, Morales M A, Sahoo S K, Leslie P D L and Labhasetwar V 2005 Iron oxide nanoparticles for sustained delivery of anticancer agents Mol. Pharm. 2 194
26. Qin J, Laurent S, Jo Y S, Roch A, Mikhaylova M, Bhujwalla Z M, Muller R N and Muhammed M 2007 A high-performance magnetic resonance imaging T2 contrast agents Adv. Mater. 19 1874
27. Liu T Y, Hu S H, Liu D M, Chen S Y and Chen I W 2009 Biomedical nanoparticle carriers with combined thermal and magnetic responses Nano. Today 4 52
28. Liu Z Y, Ding J and Xue J M 2009 A new family of biocompatible and stable magnetic nanoparticles: silica cross-linked Pluronic F127 micelles loaded with iron oxides New. J. Chem. 33 88
29. Johnston T P and Miller S C 1985 Toxicological evaluation of poloxamer vehicles for intramuscular use J. Parenter. Sci. Technol. 39 83
30. Kabanov A V, Batrakova E V and Miller D W 2003 Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier Adv. Drug. Deliv. Rev. 55 151
31. Kabanov A V, Batrakova E V, Melik-Nubarov N S, Fedoseev N A, Dorodnich T Y, Alakhov V Y, Chekhonin V P, Nazarova I R and Kabanov V A 1992 A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain J. Control Release 22 141
32. Malakooti R, Cademartiri L, Akçakir Y, Petrov S, Migliori A and Ozin G A 2006 Shape-controlled Bi2S3 nanocrystals and their plasma polymerization into flexible films Adv. Mater. 18 2189
33. Huang H H, Chen J, Meng Y Z, Yang X Q, Zhang M Z, Yu Y, Ma Z Y and Zhao Y D 2013 Synthesis and characterization of Bi2S3 composite nanoparticles with high x-ray absorption Mater. Res. Bull. 48 3800
34. Ma Y, Zhang C, Chen X N, Jiang H C, Pan S H, Easteal A J and Sun X Y 2012 The influence of modified Pluronic F127 copolymers with higher phase transition temperature on arsenic trioxide-releasing properties and toxicity in a subcutaneous model of rats Aaps. Pharmscitech. 13 441
35. Zheng Y, Lin Q Y, Jin H L, Chen J and Zhang Z H 2012 Visualization of head and neck cancer models with a triple fusion reporter gene J. Innov. Opt. Health Sci. 5 1250028
36. Zhang M Z, Yu R N, Chen J, Ma Z Y and Zhao Y D 2012 Targeted quantum dots fluorescence probes functionalized with aptamer and peptide for transferrin receptor on tumor cells Nanotechnology 23 485104
37. Yang X Q, Meng Y Z, Luo Q M and Gong H 2010 High resolution in vivo micro-CT with flat panel detector based on amorphous silicon J. X-ray. Sci. Technol. 18 381
38. Gonzales M and Krishnan K 2007 Phase transfer of highly monodisperse iron oxide nanocrystals with Pluronic F127 for biomedical applications J. Magn. Magn. Mater. 311 59
39. Chudasama B, Vala A K, Andhariya N, Mehta R V and Upadhyay R V 2010 Highly bacterial resistant silver nanoparticles: synthesis and antibacterial activities J. Nanopart. Res. 12 1677
40. Park J, Yu M K, Jeong Y Y, Kim J W, Lee K, Phanc V N and Jon S 2009 Antibiofouling amphiphilic polymer-coated superparamagnetic iron oxide nanoparticles: synthesis, characterization, and use in cancer imaging in vivo J. Mater. Chem. 19 6412
41. Chou S W, Shau Y H, Wu P C, Yang Y S, Shieh D B and Chen C C 2010 In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging J. Am. Chem. Soc. 132 13270
42. Chouly C, Pouliquen D, Lucet I, Jeune J J and Jallet P 1996 Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution J. Microencapsulation 13 245
43. Garnett M C and Kallinteri P Nanomedicines and nanotoxicology: some physiological principles Occup. Med. 56 307
44. Wang D P and Zeng L 2011 Experimental Animals Blood Physiological and Biochemical Reference Manual ed S K Shang (Beijing: Scientific Publishers) 92